Pathway Therapeutics (Anticancer Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Pathway Therapeutics (Anticancer Drug) General Information

Description

Anticancer Drug molecules and its backup compounds in San Francisco. The drug molecules and its backup compounds are used as an inhibitor to slow down the growth of cancer cells and solid tumors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 409 Illinois Street
  • San Francisco, CA 94158
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pathway Therapeutics (Anticancer Drug) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Merger/Acquisition 14-Aug-2013 Completed Product Development
To view Pathway Therapeutics (Anticancer Drug)’s complete valuation and funding history, request access »

Pathway Therapeutics (Anticancer Drug) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pathway Therapeutics Corporation Majority
To view Pathway Therapeutics (Anticancer Drug)’s complete investors history, request access »

Pathway Therapeutics (Anticancer Drug) FAQs

  • Where is Pathway Therapeutics (Anticancer Drug) headquartered?

    Pathway Therapeutics (Anticancer Drug) is headquartered in San Francisco, CA.

  • What industry is Pathway Therapeutics (Anticancer Drug) in?

    Pathway Therapeutics (Anticancer Drug)’s primary industry is Biotechnology.

  • Is Pathway Therapeutics (Anticancer Drug) a private or public company?

    Pathway Therapeutics (Anticancer Drug) is a Private company.

  • What is Pathway Therapeutics (Anticancer Drug)’s current revenue?

    The current revenue for Pathway Therapeutics (Anticancer Drug) is .

  • Who are Pathway Therapeutics (Anticancer Drug)’s investors?

    Pathway Therapeutics has invested in Pathway Therapeutics (Anticancer Drug).

  • When was Pathway Therapeutics (Anticancer Drug) acquired?

    Pathway Therapeutics (Anticancer Drug) was acquired on 14-Aug-2013.

  • Who acquired Pathway Therapeutics (Anticancer Drug)?

    Pathway Therapeutics (Anticancer Drug) was acquired by Lite Strategy.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process